Nuveen Asset Management, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$662,316
-74.9%
153,314
-61.7%
0.00%
-100.0%
Q2 2023$2,636,020
+65277.5%
400,003
-32.6%
0.00%0.0%
Q1 2023$4,032
-4.7%
593,688
+3.7%
0.00%
-50.0%
Q4 2022$4,231
-100.0%
572,615
-46.9%
0.00%
-50.0%
Q3 2022$10,660,000
-1.0%
1,078,891
+9.2%
0.00%0.0%
Q2 2022$10,766,000
-5.0%
987,785
+0.7%
0.00%0.0%
Q1 2022$11,327,000
-27.5%
980,767
-1.6%
0.00%
-20.0%
Q4 2021$15,633,000
+10.6%
996,368
+20.8%
0.01%
+25.0%
Q3 2021$14,137,000
+177.6%
824,803
+248.5%
0.00%
+100.0%
Q2 2021$5,092,000
+38.0%
236,696
-3.7%
0.00%
+100.0%
Q1 2021$3,691,000
+11.4%
245,749
-2.5%
0.00%0.0%
Q4 2020$3,313,000
+36.3%
252,138
+0.2%
0.00%0.0%
Q3 2020$2,430,000
-22.6%
251,548
-8.3%
0.00%0.0%
Q2 2020$3,139,000
-62.1%
274,444
-65.7%
0.00%
-75.0%
Q1 2020$8,284,000
-50.5%
799,691
-21.6%
0.00%
-33.3%
Q4 2019$16,736,000
+8.3%
1,019,859
-12.4%
0.01%0.0%
Q3 2019$15,459,000
+15.5%
1,164,106
+22.5%
0.01%
+20.0%
Q2 2019$13,388,000950,1470.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders